Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11520 posts found.

800px-astrazeneca_hq_in_cambridge_uk

AstraZeneca’s Lynparza recommended by the EMA for HRD-positive advanced ovarian cancer

September 21, 2020 Sales and Marketing AstraZeneca

AstraZeneca and MSD’s Lynparza (olaparib) has been recommended for marketing authorisation across the European Union for the first-line maintenance treatment …
News
800px-temazepam_10mg_tablets-1

Acella Pharmaceuticals voluntarily recalls thyroid drugs over lack of potency

September 21, 2020 Sales and Marketing thyroid, thyroid drugs

Acella Pharmaceuticals is recalling two types of its thyroid medication as the drugs may be too weak to properly treat …
News
shutterstock_159488225

Piqray and Faslodex combo extends survival in HR+/HER2-, PIK3CA+ advanced breast cancer at ESMO 2020

September 21, 2020 Research and Development, Sales and Marketing Cancer, ESMO 2020, Novartis, pharma

New data has been unveiled for the combination of Novartis’ Piqray (alpelisib) with AstraZeneca’s Faslodex (fulvestrant) in the treatment of …
News
800px-united_airlines_aircraft_taking_off_at_schiphol_airport

CDC says nearly 11,000 Americans have been exposed to COVID-19 on flights

September 21, 2020 Sales and Marketing COVID-19, air travel, coronavirus

The Centers for Disease Control and Prevention has identified nearly 11,000 people who were potentially exposed to coronavirus while flying.  …
News

Opdivo scores NICE recommendation in two non-small cell lung cancer indications

September 17, 2020 Sales and Marketing NICE, lung cancer, opdivo

NICE has announced its recommendation of Bristol-Myers Squibb’s blockbuster immunotherapy drug Opdivo (nivolumab) for the treatment of two non-small cell …
News
shutter

MSD partners up with Seattle Genetics in two oncology development deals potentially worth over $4bn

September 15, 2020 Manufacturing and Production, Sales and Marketing MSD, Seattle Genetics, deal, pharma

MSD has signed two new oncology-based deals with Seattle Genetics which together could be worth up to around $4.4 billion. …
News
spotlighton-aprile-cw_covid-19-and-cancer-1-img

Oncology research in the age of COVID-19

September 14, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CAR T, CAR-T, Cancer, feature, pharma

Matt Fellows investigates the new challenges facing the oncology space and explores the strategies that can carry it through the disruptive …
Feature
shutterstock_38078521

AstraZeneca and Oxford Uni’s COVID-19 vaccine trial resumes following safety review

September 14, 2020 Research and Development, Sales and Marketing AstraZeneca, COVID-19, Oxford University, Vaccine

After sparking a wave of concern through industry and mainstream media with the news it had halted international studies investigating …
News
shutterstock_273326141

Gilead scoops up Immunomedics in deal worth $21 billion

September 14, 2020 Sales and Marketing Gilead, Immunomedics, acquisition, pharma

The Board of Directors from both companies have unanimously agreed for Gilead to acquire Immunomedics for $88 per share in …
News
800px-logo_of_the_world_health_organization

World Health Organization reports highest one-day rise in COVID-19 infections

September 14, 2020 Sales and Marketing WHO, coronavirus

The World Health Organization has recorded the largest daily rise of coronavirus infection worldwide since the pandemic began.  This was …
News
800px-pfizer_finland_hq_february_13_2009

Pfizer CEO says company’s COVID-19 vaccine will be available this year if FDA approves the candidate by October

September 14, 2020 Sales and Marketing Pfizer, Pfizer vaccine, Vaccine

Albert Bourla, the CEO of Pfizer, has said that the company’s vaccine for COVID-19 could be used by the general …
News
donald_trump_29496131773

Trump signs order to start a process to lower US drug prices

September 14, 2020 Sales and Marketing Donald Trump drug prices, drug prices

President Trump has signed an executive order that could cut drug prices by tying them to similar prices in countries …
News
james_caggiano

Targazyme snaps up new CEO

September 11, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Targazyme, appointment

Experienced industry executive James Caggiano has been named as the new head of Californian biotech Targazyme, who will take up …
Appointment
astrazeneca_sign_sky

NICE U-turns to approve AstraZeneca’s Tagrisso in two new lung cancer indications

September 11, 2020 Medical Communications, Sales and Marketing AstraZeneca, NICE, Tagrisso

NICE has announced the recommendation of AstraZeneca’s Tagrisso (osimertinib) for routine use on the NHS in England and Wales in …
News

NICE opts to reject Celgene’s Revlimid for newly diagnosed multiple myeloma after an autologous stem cell transplant

September 11, 2020 Medical Communications, Sales and Marketing Celgene, NICE, Revlimid

It has emerged that NICE has opted to reject Celgene’s Revlimid (lenalidomide) for the maintenance of newly diagnosed multiple myeloma …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025